Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Study

---

Copy For Citation

Lang G. E., Berta A., Eldem B. M., Simader C., Sharp D., Holz F. G., ...More

OPHTHALMOLOGY, vol.120, no.10, pp.2004-2012, 2013 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 120 Issue: 10
• Publication Date: 2013
• Doi Number: 10.1016/j.ophtha.2013.02.019
• Journal Name: OPHTHALMOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.2004-2012
• Hacettepe University Affiliated: Yes

Abstract

Objective: To evaluate the 2-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema (DME).